Myo-aminoglycan for injection
Ingredients
This product contains a variety of cardiovascular active substances, the main components of which include atrial peptides, calcitonin gene-related peptides and nucleotides (nucleosides) such as adenosine triphosphate (adenosine), in addition to more than 20 amino acids and their metabolic intermediates.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| atriopeptin IIIngredients |
|
98084-69-6 | 0 | |
| ADENOSINE 5'-TRIPHOSPHATASEIngredients |
|
9000-83-3 | 0 | |
| AdenosineIngredients |
|
58-61-7 | 14 |
Indication
It promotes the body's metabolism. It is used for muscle atrophy, neurogenic edema, paralysis caused by cerebrovascular accident, neurasthenia syndrome, etc. Ischemic heart and cerebrovascular disease, diabetes, microvascular disease. Congestive heart failure. Various types of hypertension and its complications. Hemiplegia caused by cerebrovascular accident, cerebral arteriosclerosis, muscle atrophy, neurasthenia syndrome. Prevent and treat angina pectoris, myocardial infarction, toxic and hemorrhagic shock
Usage and Dosage
Intramuscular injection: 1-2 times a day or as directed by a doctor; intravenous drip: 1-2 times a day, two weeks as a course of treatment
Storage
Sealed, store in a cool dark place
Packaging Specification
Each vial contains 3.5mg of polypeptide and 0.5mg of hypoxanthine
Manufacturer
Kaifeng Kangnuo Pharmaceutical Co., Ltd.
-
Founded in:
2003-09-26 -
Address:
No. 66, South Section of Jinming Avenue, Nanyuan Street, Gulou District, Kaifeng City, Henan Province -
Tax NO.:
91410200753894686D -
Registered Funds:
8.99 million yuan -
Website:
-
Email: